Epidemiological Analysis of Severe Complicated Influenza Hospitalizations in Taiwan (2010–2020)

Overview

This retrospective review analyzed hospitalized cases of severe complicated influenza in Taiwan over an 11-year period, highlighting epidemiological trends and clinical characteristics. The study utilized national surveillance data to assess the burden and risk factors associated with severe influenza outcomes.

Background

Influenza is a globally prevalent acute viral respiratory infection causing significant morbidity and mortality annually. Severe complications such as pneumonia, encephalitis, and myocarditis can develop, especially in high-risk populations including the elderly, infants, pregnant women, and those with chronic diseases. Taiwan, with its subtropical climate, has established a national surveillance system (TNNDSS) to monitor severe influenza cases, providing valuable epidemiological data. Understanding these trends is critical for improving prevention and management strategies.

Data Highlights

The study used data from the Taiwan National Notifiable Disease Statistics System (TNNDSS) covering hospitalized severe complicated influenza cases from 2010 to 2020. Cases were laboratory-confirmed via viral culture, immunofluorescence, RT-PCR, or rapid diagnostic tests. Surveillance included respiratory specimen collection within 14 days of positive influenza testing. The dataset included demographic and clinical information enabling epidemiological analysis.

Key Findings

• Severe complicated influenza cases in Taiwan are predominantly domestic, with few imported cases reported.
• Influenza A virus subtypes A(H3N2) and A(H1N1), and influenza B strains B/Victoria and B/Yamagata, are the main causes of seasonal epidemics leading to severe complications.
• High-risk groups for severe influenza complications include older adults (>65 years), infants, pregnant women, immunocompromised individuals, and patients with chronic diseases or obesity (BMI ≥ 30 kg/m2).
• Most severe cases present with pneumonia, neurologic symptoms, or myopericarditis, necessitating hospitalization.
• Influenza virus transmission occurs mainly via respiratory droplets and contact with contaminated surfaces, with animal reservoirs contributing to the emergence of new influenza A subtypes.
• Annual influenza vaccination remains the most effective preventive measure against severe influenza complications.

Clinical Implications

Clinicians should maintain heightened vigilance for severe influenza complications in high-risk populations and consider early diagnostic testing and antiviral treatment. Influenza vaccination should be strongly recommended, especially for vulnerable groups, to reduce hospitalization rates and severe outcomes. Surveillance data support targeted public health interventions to mitigate influenza burden in Taiwan.

Conclusion

This epidemiological review underscores the significant impact of severe complicated influenza in Taiwan and highlights the importance of continued surveillance, vaccination, and clinical awareness to reduce morbidity and mortality associated with influenza infections.

Related Resources & Content

1. WHO -- Influenza Fact Sheet
2. Taiwan Centers for Disease Control -- TNNDSS Surveillance System